Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vanessa L. Clark, Peter G. Gibson, Vanessa M. McDonald. What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance. ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020

Member's Comments

No comment yet.

Related content which might interest you: Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 What do patients want? Preferences for two asthma regimens in mild/moderate asthma Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 Are a degree of asthma therapy related to asthma control impairment? Source: Eur Respir J 2003; 22: Suppl. 45, 370s Year: 2003 Examining the unmet need in inadequately controlled severe allergic asthma Source: Annual Congress 2004 - Anti-IgE: Addressing the unmet need in inadequately controlled severe allergic asthma Year: 2004 Recognising and addressing the psychosocial and behavioural aspects of COPD and asthma patients Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases Year: 2004 Examining the unmet need in adults with severe asthma Source: Eur Respir Rev 2007; 16: 67-72 Year: 2007 High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs Source: Eur Respir J 2012; 40: 1149-1155 Year: 2012 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Development of the assessment of illness expectations in people with asthma Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004 Impact of add-on medications on patient‘s satisfaction in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 273s Year: 2005 Self-care behavior for medications use and treatment outcome in elderly with asthma Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems Year: 2010 The Anglo-French real-life experience of maintenance OCS use in omalizumab-treated patients with severe persistent allergic asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting Source: International Congress 2017 – Asthma management Year: 2017 Defining acute asthma severity – how do worldwide asthma guidelines compare? Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018 Balancing treatment and side-effects in severe asthma: a patient and professional perspective Source: Breathe, 17 (2) 210045; 10.1183/20734735.0045-2021 Year: 2021 Overweight children with asthma - are attribution of symptoms and treatment regimens appropriate? Source: Eur Respir J 2002; 20: Suppl. 38, 333s Year: 2002 Age-related differences in perceived asthma control in childhood: guidelines and reality Source: Eur Respir J 2002; 20: 880-889 Year: 2002 Comorbidities in asthma, what impact? Source: International Congress 2018 – Tests and trends in asthma Year: 2018